Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis - No Study Results Posted

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis (PRISTINE-)

This study is ongoing, but not recruiting participants.

Study NCT00663052 Information provided by Wyeth is now a wholly owned subsidiary of Pfizer

First Received: April 17, 2008 Last Updated: June 28, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	October 2009
Estimated Primary Completion Date:	October 2009 (Final data collection date for primary outcome measure)